查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386122

水痘疫苗市场报告：2030 年趋势、预测与竞争分析

Chickenpox Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

水痘疫苗趋势和预测

预计到 2030 年，全球水痘疫苗市场将达到 46 亿美元，2024 年至 2030 年复合年增长率为 5.8%。该市场的主要驱动因素是世界各地免疫计划的增加、公众对水痘疫苗使用的认识的提高以及政府对免疫计划的贡献的增加。由于医院和诊所市场的商机，全球水痘疫苗市场的未来前景看好。

水痘疫苗市场洞察

Lucintel 预测，带状疱疹在预测期内将经历最高的增长。

预计在预测期内医院市场将出现高速成长。

由于完善的疫苗接种计划以及人口增长对疫苗接种率的需求不断增加，北美仍然是最大的地区。

市场规模/估计：以金额的水痘疫苗市场规模估计（10 亿美元）。

趋势和预测分析：各个细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）。

按细分市场分析：按产品类型、应用、最终用途和地区估算水痘疫苗的市场规模（以金额）。

区域分析：北美、欧洲、亚太地区和世界其他地区的水痘疫苗市场区隔。

成长机会：按产品类型、应用、最终用途和地区对水痘疫苗市场进行成长机会分析。

策略分析：水痘疫苗市场併购、新产品开发、竞争形势等。

基于波特五力模型的产业竞争实力分析。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球水痘疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球水痘疫苗市场趋势（2018-2023）与预测（2024-2030）
  • 按产品类型分類的全球水痘疫苗市场
    • 单价水痘疫苗
    • 水痘联合疫苗
  • 全球水痘疫苗市场按应用
    • 腮腺炎
    • 麻疹
    • 德国麻疹
    • 水痘疫苗接种
    • 带状疱疹
    • 免疫
  • 全球水痘疫苗市场（依最终用途）
    • 医院
    • 诊所
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球水痘疫苗市场区域分布
  • 北美水痘疫苗市场
  • 欧洲水痘疫苗市场
  • 亚太水痘疫苗市场
  • 其他地区水痘疫苗市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球水痘疫苗市场成长机会
    • 全球水痘疫苗市场成长机会（按应用）
    • 全球水痘疫苗市场成长机会（依最终用途）
    • 全球水痘疫苗市场成长机会（按地区）
  • 全球水痘疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球水痘疫苗市场产能扩张
    • 全球水痘疫苗市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • Bio-Med
  • GlaxoSmithKline
  • Emcure Pharmaceuticals
  • Novo Medi Services
  • Sanofi
  • Takeda Pharmaceutical
  • Changchun BCHT Biotechnology
  • Green Cross Holdings
  • Merck
  • Mitsubishi Chemical Holdings
简介目录

Chickenpox Vaccine Trends and Forecast

The future of the global chickenpox vaccine market looks promising with opportunities in the hospital and clinic markets. The global chickenpox vaccine market is expected to reach an estimated $4.6 billion by 2030 with a CAGR of 5.8% from 2024 to 2030. The major drivers for this market are increasing number of vaccination programs throughout the world, rising public awareness of the use of chickenpox vaccines, and growing government contribution in immunization programs.

A more than 150-page report is developed to help in your business decisions.

Chickenpox Vaccine by Segment

The study includes a forecast for the global chickenpox vaccine by product type, application, end use, and region.

Chickenpox Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Monovalent Varicella Vaccine
  • Combination Varicella Vaccine

Chickenpox Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Mumps
  • Measles
  • Rubella
  • Varicella Immunization
  • Herpes Zoster
  • Immunization
  • Chickenpox Vaccination

Chickenpox Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Others

Chickenpox Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Chickenpox Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chickenpox vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chickenpox vaccine companies profiled in this report include-

  • Bio-Med
  • GlaxoSmithKline
  • Emcure Pharmaceuticals
  • Novo Medi Services
  • Sanofi
  • Takeda Pharmaceutical
  • Changchun BCHT Biotechnology
  • Green Cross Holdings
  • Merck
  • Mitsubishi Chemical Holdings

Chickenpox Vaccine Market Insights

Lucintel forecasts that herpes zoster is expected to witness highest growth over the forecast period.

Within this market, hospital is expected to witness higher growth over the forecast period.

North America will remain the largest region due to presence of well-established vaccination program and growing demand for vaccine coverage rate with expanding population in the region.

Features of the Global Chickenpox Vaccine Market

Market Size Estimates: Chickenpox vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Chickenpox vaccine market size by product type, application, end use, and region in terms of value ($B).

Regional Analysis: Chickenpox vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, end uses, and regions for the chickenpox vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chickenpox vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the chickenpox vaccine market size?

Answer: The global chickenpox vaccine market is expected to reach an estimated $4.6 billion by 2030.

Q.2 What is the growth forecast for chickenpox vaccine market?

Answer: The global chickenpox vaccine market is expected to grow with a CAGR of 5.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the chickenpox vaccine market?

Answer: The major drivers for this market are increasing number of vaccination programs throughout the world, rising public awareness of the use of chickenpox vaccines and growing government contribution in immunization programs.

Q4. What are the major segments for chickenpox vaccine market?

Answer: The future of the chickenpox vaccine market looks promising with opportunities in the hospital and clinic markets.

Q5. Who are the key chickenpox vaccine market companies?

Answer: Some of the key chickenpox vaccine companies are as follows:

  • Bio-Med
  • GlaxoSmithKline
  • Emcure Pharmaceuticals
  • Novo Medi Services
  • Sanofi
  • Takeda Pharmaceutical
  • Changchun BCHT Biotechnology
  • Green Cross Holdings
  • Merck
  • Mitsubishi Chemical Holdings

Q6. Which chickenpox vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that herpes zoster is expected to witness highest growth over the forecast period.

Q7. In chickenpox vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to presence of well-established vaccination program and growing demand for vaccine coverage rate with expanding population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the chickenpox vaccine market by product type (monovalent varicella vaccine and combination varicella vaccine), application (mumps, measles, rubella, varicella immunization, herpes zoster, immunization, and chickenpox vaccination), end use (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Chickenpox Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Chickenpox Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Chickenpox Vaccine Market by Product Type
    • 3.3.1: Monovalent Varicella Vaccine
    • 3.3.2: Combination Varicella Vaccine
  • 3.4: Global Chickenpox Vaccine Market by Application
    • 3.4.1: Mumps
    • 3.4.2: Measles
    • 3.4.3: Rubella
    • 3.4.4: Varicella Immunization
    • 3.4.5: Herpes Zoster
    • 3.4.6: Immunization
    • 3.4.7: Chickenpox Vaccination
  • 3.5: Global Chickenpox Vaccine Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Clinics
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Chickenpox Vaccine Market by Region
  • 4.2: North American Chickenpox Vaccine Market
    • 4.2.1: North American Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
    • 4.2.2: North American Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others
  • 4.3: European Chickenpox Vaccine Market
    • 4.3.1: European Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
    • 4.3.2: European Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others
  • 4.4: APAC Chickenpox Vaccine Market
    • 4.4.1: APAC Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
    • 4.4.2: APAC Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others
  • 4.5: ROW Chickenpox Vaccine Market
    • 4.5.1: ROW Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
    • 4.5.2: ROW Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Chickenpox Vaccine Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Chickenpox Vaccine Market by Application
    • 6.1.3: Growth Opportunities for the Global Chickenpox Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Chickenpox Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Chickenpox Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Chickenpox Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chickenpox Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bio-Med
  • 7.2: GlaxoSmithKline
  • 7.3: Emcure Pharmaceuticals
  • 7.4: Novo Medi Services
  • 7.5: Sanofi
  • 7.6: Takeda Pharmaceutical
  • 7.7: Changchun BCHT Biotechnology
  • 7.8: Green Cross Holdings
  • 7.9: Merck
  • 7.10: Mitsubishi Chemical Holdings